Who owns Atea Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AVIR from SEC Form 13F filings across 127 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 127 institutions disclosed 60.7M shares of Atea Pharmaceuticals, Inc. worth $269.9M — about 75.9% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
127
13F holders
$269.9M
value, 2026 filers
75.9%
of shares outstanding (60.7M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of AVIR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 12.0M | $55.8M | 0.0% | 15% | +0.4% |
| 2 | BlackRock, Inc. | 8.7M | $40.5M | 0.0% | 10.9% | +3.4% |
| 3 | BML Capital Management, LLC | 7.0M | $32.3M | 18.4% | 8.7% | -1.5% |
| 4 | TANG CAPITAL MANAGEMENT LLC | 4.8M | $22.4M | 1.0% | 6% | 0.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $13.8M | 0.0% | 3.7% | -8.7% |
| 6 | Bain Capital Life Sciences Investors, LLC | 2.1M | $9.7M | 0.6% | 2.6% | -12.1% |
| 7 | ACADIAN ASSET MANAGEMENT LLC | 2.0M | $9,455 | 0.0% | 2.5% | +28.6% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.0M | $9.1M | 0.0% | 2.4% | +12.1% |
| 9 | STATE STREET CORP | 1.7M | $7.7M | 0.0% | 2.1% | -2.5% |
| 10 | TWO SIGMA INVESTMENTS, LP | 1.5M | $7.0M | 0.0% | 1.9% | -19.2% |
| 11 | DIMENSIONAL FUND ADVISORS LP | 1.3M | $6.0M | 0.0% | 1.6% | +3.5% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 1.1M | $5.3M | 0.0% | 1.4% | -3.0% |
| 13 | Rosalind Advisors, Inc. | 1.1M | $5.0M | 1.8% | 1.3% | -8.6% |
| 14 | JPMORGAN CHASE & CONEW | 945,918 | $4.4M | 0.0% | 1.2% | new |
| 15 | NORTHERN TRUST CORP | 755,239 | $3.5M | 0.0% | 0.9% | +29.1% |
| 16 | MORGAN STANLEY | 719,514 | $3.3M | 0.0% | 0.9% | -1.6% |
| 17 | Curated Wealth Partners LLCNEW | 695,000 | $670,675 | 0.1% | 0.9% | new |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 630,185 | $2.9M | 0.0% | 0.8% | +13.0% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 610,607 | $2.8M | 0.0% | 0.8% | +2.3% |
| 20 | Sixth Street Partners Management Company, L.P.NEW | 610,607 | $2.8M | 0.5% | 0.8% | new |
| 21 | GOLDMAN SACHS GROUP INC | 530,856 | $2.5M | 0.0% | 0.7% | -9.8% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 469,801 | $2.2M | 0.0% | 0.6% | -3.1% |
| 23 | CM Management, LLC | 355,000 | $1.7M | 1.1% | 0.4% | 0.0% |
| 24 | BARCLAYS PLC | 348,653 | $1.6M | 0.0% | 0.4% | +116.6% |
| 25 | D. E. Shaw & Co., Inc. | 345,186 | $1.6M | 0.0% | 0.4% | -9.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.